Indian officials. Photo: MEA/Flickr
Indian pharmaceutical group Bharat Biotech said on Tuesday that it will “probably” export millions of its Covaxin vaccine to the United Arab Emirates and Brazil later this week.
Covaxin obtained regulatory clearance in India on January 3, despite a lack of data attesting to its safety and efficacy. Results of advanced trials with 25,800 participants will only be disclosed in March. Still, Indian regulators stand by their position, citing a test with 26 patients to say that the vaccine is effective against new variants of the coronavirus.
Bharat Biotech has filed for authorization to run phase 3 trials in Brazil, but a recent move by Brazilian health regulator Anvisa lifted the requirement for local trials to obtain emergency approval.
Support this coverage →The relationship between farmers and the Luiz Inácio Lula da Silva administration is by no…
Pelé, Ronaldo, Zico, Marta … All of Brazil’s truly immortal sporting icons are footballers, that…
Speaking before a Senate hearing on Tuesday, Chief of Staff Rui Costa admitted that Brazil…
New job market data from the Brazilian Institute of Geography and Statistics (IBGE) show the…
Brazil officially had 5.83 million domestic workers in 2022 — almost the entire population of…
Brazil’s Ministry of Health this month announced a purchase of 12.5 million doses of Moderna’s…